Skip to main content

Find Clinical Trials

Home
Conditions
HR+/HER2- Advanced/Metastatic Breast Cancer

Clinical trial condition

HR+/HER2- Advanced/Metastatic Breast Cancer

Explore clinical trials studying HR+/HER2- Advanced/Metastatic Breast Cancer. Study availability and eligibility vary by location and protocol.

2 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

HR+/HER2- Advanced/Metastatic Breast Cancer trial results

Not Yet Recruiting

Sirolimus for Injection (Albumin-bound) Combined With Fulvestrant for HR+/HER2- Advanced/Metastatic Breast Cancer Patients Previously Treated With CDK4/6 Inhibitors

NCT06929325

Conditions: Breast Diseases, Breast Neoplasms, HR+/HER2- Advanced/Metastatic Breast Cancer, +4 more
Locations: Clinical Trials Information Group Shijiazhuang, Hebei, China

View Trial Details

Active, Not Recruiting

Sirolimus for Injection (Albumin-bound) in Combination With Endocrine Therapy for HR+/HER2- Advanced/Metastatic Breast Cancer Patients Who Have Failed Standard Therapy

NCT06957379

Conditions: Breast Diseases, Breast Neoplasms, HR+/HER2- Advanced/Metastatic Breast Cancer, +4 more
Locations: Cancer Hospital, Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China

View Trial Details